Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-24 @ 4:45 PM
NCT ID:
NCT00896350
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed squamous cell carcinoma of the head and neck
* Stage III or IV disease
* Measurable disease
* Scheduled to undergo standard treatment including radiation therapy and chemotherapy
* Participation on study # 092004-010 for tissue procurement
PATIENT CHARACTERISTICS:
* ECOG performance status 0-2
* Serum creatinine ≤ 1.5 OR creatinine clearance ≥ 40
* Body mass index ≤ 34 Kg/m\^2
* Not claustrophobic
* No other contraindications to MRI (i.e., implanted pacemaker device)
* Not pregnant or nursing
* Negative pregnancy test
* No allergy to gadolinium
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00896350
Study Brief:
Protocol Section:
NCT00896350